Angiodynamics Inc (ANGO)
- Sector
- Health Care
- Last price
- $12.13
- As of
Kresmion compiles this page from ANGO's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
ANGIODYNAMICS INC (ANGO): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-10-08.
See the full ANGO dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ANGO on one page. Preview it with sample data, then open it live with a free account.
Preview the ANGO dossierActive events for ANGO
- high13F: large reduction
CITADEL ADVISORS LLC cut 75% of ANGO (2026Q2)
- mediumEarnings above estimates
Q3-2026: Beat consensus by 117.8%, EPS $0.02 vs $-0.1122 estimate
- mediumEarnings above estimates
Q4-2026: Beat consensus by 23.7%, EPS $-0.07 vs $-0.0918 estimate
FREE, NO ACCOUNT
Every event on ANGO, as it fires
New filings, 13F moves and cross asset events on ANGO land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in ANGO (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| Point72 Asset Management, L.P.CUSIP 03475V101 · 2026Q2 | $39.8M | 0.04% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 03475V101 · 2026Q2 | $10.2M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 03475V101 · 2026Q2 | $9.5M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 03475V101 · 2026Q2 | $4M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 03475V101 · 2026Q2 | $162K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, ANGO
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
ANGO against its peers
ANGO's operating margin of -12.5% ranks in the 33rd percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-08-31 and 2026-05-31.
| Metric | ANGO | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 320M USD | 344M USD | 44 | 25 |
| Gross margin | 54.6% | 61.0% | 44 | 16 |
| Operating margin | -12.5% | -4.6% | 33 | 25 |
| Net margin | -11.5% | -7.7% | 37 | 25 |
| Return on equity | -21.5% | -8.7% | 34 | 24 |
| P / E | n/a | 46.2x | n/a | 6 |
Peers (25): EVH, SGHT, FLGT, CERS, CCRN.D, CTEV, EHAB.D, SLP, VREX, AHCO, TALK.D, CSTL, BVS, HSTM, IRMD, PRCT, OMDA, GDRX, STAA, TDOC, USPH, RXST, TNDM, CNMD, INGN. Fiscal periods ending between 2025-08-31 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (ANGO: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow ANGO on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to ANGO for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.